$AMRN News Article - National Lipid Association's New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins
https://marketwirenews.com/news-releases/nati...15024.html